{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:02Z","timestamp":1787027282416,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["122679"],"award-info":[{"award-number":["122679"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["139467"],"award-info":[{"award-number":["139467"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["148493"],"award-info":[{"award-number":["148493"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["177519"],"award-info":[{"award-number":["177519"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Substance-induced consciousness alterations (CA) have mainly been studied among users of psychedelics but not among people using street drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Explore occurrences of three different types of substance-induced CA [ego dissolution (ED), visual pseudo-hallucinations (VPH), anxiety\/paranoia (A\/P)] and their perceived influences on life, together with their associations with substance use and personality correlates in a general population sample of 25-year-old men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>2,796 young Swiss men lifetime substance users completed a self-report questionnaire including history of use (never, former, and current) of different substances categories (psychedelics, cocaine, psychostimulants, ecstasy, MDMA, and other drugs), substance-induced ego dissolution (ED), visual pseudo-hallucinations (VPH) and anxiety\/paranoia (A\/P), the influence of these CA experiences on life, and personality traits (sensation seeking, sociability, anxiety-neuroticism, and aggression\u2013hostility).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>32.2% reported at least one CA (i.e., ED, VPH or A\/P), with 20.5% reporting ED, 16.7% VPH, and 14.6% A\/P. Former and current use of psychedelics and ketamine was significantly associated with occurrences of all three types of CAs and with a positive influence of CA on life. Associations between the former and current use of other substances and the different types of CA were less consistent, and perceived influences on life were not statistically significant. Sociability was negatively associated with occurrences of all three types of CA. Positive associations were found between anxiety\u2013neuroticism and ED and A\/P, between aggression\u2013hostility and A\/P, and between sensation seeking and ED and VPH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study supports the potential for psychedelics to induce CAs perceived as beneficial to life among people using street drugs, possibly reflecting the mechanism underlying the therapeutic potential of psychedelics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2022.1056159","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:59:46Z","timestamp":1672833586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Consciousness alterations in a cohort of young Swiss men: Associations with substance use and personality traits"],"prefix":"10.3389","volume":"13","author":[{"given":"Marianthi Lousiana","family":"Deligianni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Khazaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bertholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (Ascs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol Therap."},{"key":"B3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.31887\/DCNS.2001.3.4\/fxvollenweider","article-title":"Brain mechanisms of hallucinogens and entactogens","volume":"3","author":"Vollenweider","year":"2001","journal-title":"Dialog Clin Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/schbul\/sbz102","article-title":"Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis","volume":"46","author":"Murrie","year":"2020","journal-title":"Schizoph Bull."},{"key":"B6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis","volume":"175","author":"Starzer","year":"2018","journal-title":"Am J Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.3390\/ijerph18136944","article-title":"Club drugs and psychiatric sequelae: an issue of vulnerability and previous psychiatric history","volume":"18","author":"Martinotti","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/S1092852920001479","article-title":"Substance-related exogenous psychosis: a postmodern syndrome","volume":"26","author":"Martinotti","year":"2021","journal-title":"CNS Spect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","article-title":"Psychosis associated with acute recreational drug toxicity: a European case series","volume":"16","author":"Vallersnes","year":"2016","journal-title":"BMC Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000317249","article-title":"Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population","volume":"16","author":"Van Amsterdam","year":"2010","journal-title":"Eur Addict Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/02791072.2019.1571258","article-title":"Comparing mental health across distinct groups of users of psychedelics, Mdma, psychostimulants, and cannabis","volume":"51","author":"Rougemont-B\u00fccking","year":"2019","journal-title":"J Psychoact Drugs."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e63972","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and mental health: a population study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS ONE."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet."},{"key":"B14","unstructured":"2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0269881114568040","article-title":"Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?","volume":"29","author":"Maji\u0107","year":"2015","journal-title":"J Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","article-title":"Investigation of sex-dependent effects of cannabis in daily cannabis smokers","volume":"136","author":"Cooper","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"B18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","article-title":"Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness","volume":"88","author":"Koethe","year":"2006","journal-title":"Schizoph Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"109118","DOI":"10.1016\/j.drugalcdep.2021.109118","article-title":"Cannabis use disorder and dissociation: a report from a prospective first-episode psychosis study","volume":"229","author":"Ricci","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1017\/S0033291712001924","article-title":"Cannabis affects people differently: inter-subject variation in the psychotogenic effects of \u03b49-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers","volume":"43","author":"Atakan","year":"2013","journal-title":"Psychol Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: a prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/0269881121998322","article-title":"Prediction of Mdma response in healthy humans: a pooled analysis of placebo-controlled studies","volume":"35","author":"Studerus","year":"2021","journal-title":"J Psychopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0269881121997099","article-title":"Cannabis-induced oceanic boundlessness","volume":"35","author":"Earleywine","year":"2021","journal-title":"J Psychopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.paid.2017.06.004","article-title":"Neuroticism is associated with challenging experiences with psilocybin mushrooms","volume":"117","author":"Barrett","year":"2017","journal-title":"Personal Individ Differ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neubiorev.2018.02.004","article-title":"Serotonergic psychedelics and personality: a systematic review of contemporary research","volume":"87","author":"Bouso","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e30800","DOI":"10.1371\/journal.pone.0030800","article-title":"Prediction of psilocybin response in healthy volunteers","volume":"7","author":"Studerus","year":"2012","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J Psychopharmacol."},{"key":"B29","unstructured":"2021"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (Oav)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.paid.2006.03.001","article-title":"Cross-cultural shortened form of the Zkpq (Zkpq-50-Cc) adapted to English, French, German, and Spanish languages","volume":"41","author":"Aluja","year":"2006","journal-title":"Person Individ Differ."},{"key":"B32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0191-8869(01)00032-0","article-title":"Reliability and validity of a brief measure of sensation seeking","volume":"32","author":"Hoyle","year":"2002","journal-title":"Person Individ Differ."},{"key":"B33","author":"IBM","year":"2020","journal-title":"Ibm Spss Statistics for Windows, Version 27"},{"key":"B34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/03610911003650383","article-title":"How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies","volume":"39","author":"Chen","year":"2010","journal-title":"Commun Stat Simul Comput."},{"key":"B35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neubiorev.2020.03.017","article-title":"Long-term effects of psychedelic drugs: a systematic review","volume":"113","author":"Aday","year":"2020","journal-title":"Neurosci Biobehav Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.drugalcdep.2013.12.019","article-title":"Therapeutic infusions of ketamine: do the psychoactive effects matter?","volume":"136","author":"Dakwar","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"B37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2015","journal-title":"Curr Drug Abuse Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fpsyt.2018.00603","article-title":"review of risk factors for methamphetamine-related psychiatric symptoms","volume":"9","author":"Chang","year":"2018","journal-title":"Front Psychiatry."},{"key":"B39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1080\/15563650.2021.1884693","article-title":"Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on european emergency departments","volume":"59","author":"Mir\u00f3","year":"2021","journal-title":"Clin Toxicol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"110263","DOI":"10.1016\/j.pnpbp.2021.110263","article-title":"A systematic review and meta-analysis of the prevalence of cocaine-induced psychosis in cocaine users","volume":"109","author":"Sabe","year":"2021","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum Psychopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2017.03.032","article-title":"Co-occurrence of tobacco product use, substance use, and mental health problems among adults: findings from wave 1 (2013\u20132014) of the population assessment of tobacco and health (path) study","volume":"177","author":"Conway","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1471-244X-11-202","article-title":"The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey","volume":"11","author":"Saha","year":"2011","journal-title":"BMC Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3109\/16066359.2010.489999","article-title":"Cannabis causes schizophrenia? So does nicotine","volume":"18","author":"Zullino","year":"2010","journal-title":"Addict Res Theory."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(07)61653-5","article-title":"Cannabis and psychosis","volume":"370","author":"Zullino","year":"2007","journal-title":"Lancet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","article-title":"Predicting reactions to psychedelic drugs: a systematic review of states and traits related to acute drug effects","volume":"4","author":"Aday","year":"2021","journal-title":"ACS Pharmacol Transl Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1348\/014466510X491397","article-title":"Neuroticism explained? From a non-informative vulnerability marker to informative person: context interactions in the realm of daily life","volume":"50","author":"Jacobs","year":"2011","journal-title":"Br J Clin Psychol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.concog.2010.05.013","article-title":"The experience of altered states of consciousness in shamanic ritual: the role of pre-existing beliefs and affective factors","volume":"19","author":"Polito","year":"2010","journal-title":"Consc Cognit."},{"key":"B49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/per.2045","article-title":"Cross\u2013Cultural generalizability of the alternative five\u2013factor model using the Zuckerman\u2013Kuhlman\u2013Aluja personality questionnaire","volume":"30","author":"Rossier","year":"2016","journal-title":"Eur J Person."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J Psychopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J Psychopharmacol."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1056159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:59:49Z","timestamp":1672833589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1056159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":51,"alternative-id":["10.3389\/fpsyt.2022.1056159"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.1056159","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1056159"}}